Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
LogisticsBiotechnology Equipment

PUBLISHER: Visiongain | PRODUCT CODE: 1790701

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1790701

Cell & Gene Therapy Cold Chain Logistics Market Report 2025-2035

PUBLISHED:
PAGES: 422 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User) - 1 Year License
USD 5872.50
PDF (Team License - Up to 6 Users) - 1 Year License
USD 6952.50
PDF (Site License)
USD 8167.50
PDF (Enterprise License - Includes Free Datasets)
USD 10320.75

Add to Cart

Description

Table of Contents

List of Tables

The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 16.5% by 2035

The Cell & Gene Therapy Cold Chain Logistics Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

High Prevalence of Cancer and Genetic Disorders Driving the Market Growth

Cancer remains one of the leading causes of mortality and morbidity globally, with its rising prevalence fuelled by factors such as sedentary lifestyles, increased alcohol and tobacco use, and limited awareness in underdeveloped regions. Alongside this, the burden of rare diseases is growing rapidly. According to a WHO report dated 24 May 2025, over 300 million people worldwide approximately 1 in every 17 are living with a rare disease. This surge in complex, often life-threatening conditions is significantly boosting the demand for advanced cell and gene therapies, many of which are tailored to individual patients and require precise handling to ensure efficacy.

Given their temperature sensitivity and complex storage needs, cell and gene therapies rely heavily on sophisticated cold chain logistics systems. These therapies often need to be transported and stored at ultra-low or cryogenic temperatures, requiring specialised packaging, real-time temperature monitoring, and localised storage infrastructure near treatment centres. In response, logistics providers are investing in innovative solutions such as smart cryogenic containers, decentralised cold chain hubs, and integrated digital platforms for end-to-end traceability. As more therapies gain regulatory approval and enter the market, these enhanced logistics capabilities are becoming critical to expanding patient access, ensuring that transformative treatments can be delivered safely and efficiently across diverse geographic regions.

Absence of Adequate Infrastructure for Cold Chain Logistics in Developing Nations is Hindering the Market Growth

The lack of robust cold chain infrastructure in developing countries and remote regions presents significant barriers to the effective distribution of cell and gene therapies, which require stringent temperature control to maintain their viability. A critical issue is the shortage of reliable refrigeration systems, which are vital for safeguarding the integrity of temperature-sensitive biologics during storage and transport. In areas where electricity supply is unstable or inconsistent, maintaining the required cold chain conditions becomes nearly impossible, increasing the risk of product degradation. To overcome this, innovative solutions are emerging such as those offered by Sure Chill, whose alternative cooling technology can maintain stable temperatures without continuous power supply, making it ideal for use in electricity-deficient settings.

These infrastructure limitations also hinder broader healthcare delivery, including the preservation and distribution of vaccines, which share similar cold chain requirements. For example, a study in Ethiopia's East Gojam zone (Amhara region) highlighted major gaps in cold chain readiness: only 76.7% of health facilities had functional refrigerators, 35% had backup generators, and less than half had vehicles available to support vaccine transport during equipment or power outages. Compounding the issue, just 38.3% of healthcare workers were found to have adequate knowledge of cold chain management. These findings underscore the urgent need for targeted investments in infrastructure, training, and innovation to strengthen cold chain logistics in underserved regions ensuring equitable access to advanced therapies and improving global health outcomes.

What would be the Impact of US Trade Tariffs on the Global Cell and Gene Therapy Cold Chain Logistics Market?

The imposition of the U.S. trade tariffs can significantly disrupt the global cell and gene therapy (CGT) cold chain logistics market, which relies heavily on international coordination and seamless cross-border movement of temperature-sensitive materials. Tariffs on critical components such as cryogenic containers, temperature-monitoring devices, or even specific raw materials used in therapy manufacturing could lead to higher costs across the supply chain. For logistics providers, this would mean increased operational expenses, potential delays due to customs clearance complications, and the need to reconfigure sourcing strategies. These changes could compromise the time-sensitive nature of CGT delivery, affecting therapy efficacy and regulatory compliance.

Moreover, countries impacted by US tariffs may retaliate with their own trade restrictions, further fragmenting the cold chain ecosystem. For global biopharmaceutical companies, this could result in a re-evaluation of manufacturing and distribution hubs, with a shift toward more localised supply chains to minimise tariff exposure. Smaller CGT firms, already burdened by high production and regulatory costs, may struggle to absorb tariff-induced price increases, leading to delays in commercialisation or limited patient access. In the long term, such trade tensions could incentivise innovation in local cold chain infrastructure and strategic alliances, but they would also reduce global interoperability and increase barriers to international collaboration in advanced therapies.

In addition to cost and supply chain disruptions, US trade tariffs can also hinder the global scalability of emerging cell and gene therapies. Many CGT developers rely on specialised equipment, reagents, or packaging materials sourced from international suppliers, and tariffs can lead to bottlenecks in procurement or force reliance on lower-quality alternatives. This not only affects production timelines but also raises concerns about product stability and compliance with Good Distribution Practices (GDP). Furthermore, tariffs may discourage global logistics companies from investing in cross-border infrastructure improvements, especially in emerging markets, slowing the development of a globally harmonised cold chain network. Overall, such trade barriers can delay patient access to life-saving therapies and increase inequality in treatment availability between developed and developing regions.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the cell and gene therapy cold chain logistics market evolving?
  • What is driving and restraining the cell and gene therapy cold chain logistics market?
  • How will each cell and gene therapy cold chain logistics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each cell and gene therapy cold chain logistics submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading cell and gene therapy cold chain logistics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the cell and gene therapy cold chain logistics projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of cell and gene therapy cold chain logistics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the cell and gene therapy cold chain logistics market?
  • Where is the cell and gene therapy cold chain logistics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell and gene therapy cold chain logistics market today, and over the next 10 years:

  • Our 422-page report provides 176 tables and 204 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analysis reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analysis, with business outlooks and developments.
  • Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising cell and gene therapy cold chain logistics prices and recent developments.

Segments Covered in the Report

  • Component
  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra-Low Freezers
  • Cold Chain Management Systems
  • Shipment and Storage Medium
  • Cryogenic Packout Kits
  • Others
  • Services
  • Transportation
  • Storage
  • Packaging
  • Mode of Transport
  • Air Transport
  • Ground Transport
  • Water Transport
  • Holding Temperature Range
  • Cryogenic
  • Refrigerated
  • Ambient
  • Others
  • End-users
  • Biopharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Belgium
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Malaysia
  • Thailand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies profiled in the report
  • A.P. M√∏ller - Maersk
  • Arvato SE
  • Atelerix Ltd.
  • BioLife Solutions Inc.
  • BioStor Sytems Inc.
  • Cardinal Health
  • Catalent Inc.
  • Cencora, Inc.
  • CEVA Logistics
  • CryoPort Inc.
  • DB Schenker
  • Delhivery Limited
  • DHL
  • FedEx
  • Marken (a UPS Company)
  • MasterControl Solutions, Inc.
  • Modality Solutions
  • NMDP BioTherapies
  • Nordic Cold Chain Solutions
  • Polar Express Transportation
  • sedApta s.r.l.
  • Thermo Fisher Scientific Inc.
  • TrakCel
  • Yourway
  • YUSEN LOGISTICS

Overall world revenue for Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035 in terms of value the market will surpass US$2,165.9 million in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035 report help you?
  • In summary, our 420+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035, with forecasts for component, services, mode of transport, holding temperature range, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 21 key national markets - See forecasts for the Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Cell and Gene Therapy Cold Chain Logistics Market, 2025 to 2035.
  • Find quantitative and qualitative analysis with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Show more
Product Code: PHA1356

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Cell and Gene Therapy Cold Chain Logistics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Advancements in Storage and Transportation of Biologics
      • 3.3.1.2 Increasing Adoption of Gene and Cell Therapies
      • 3.3.1.3 High Prevalence of Cancer and Genetic Disorders
      • 3.3.1.4 Technological Advancements
      • 3.3.1.5 Increasing Strategic Initiatives Among Market Players
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 High Cost of Cell and Gene Therapy Storage and Transportation
      • 3.3.2.2 Absence of Adequate Infrastructure for Cold Chain Logistics in Developing Nations
      • 3.3.2.3 Supply Chain Disruptions
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Strong Clinical Pipeline and Increasing Approval for Cell and Gene Therapy Products
      • 3.3.3.2 Lucrative Opportunities in Developing Countries
      • 3.3.3.3 Stringent Government Regulations for Cell & Gene Therapy Boosts the Market Growth
      • 3.3.3.4 Favourable Initiatives and Programs for Easier Access to Cell and Gene Therapy
  • 3.4 U.S. Tariffs: What's the Impact on Global Cell and Gene Therapy Cold Chain Logistics Market?
    • 3.4.1 Overview
    • 3.4.2 V-Shaped Recovery Scenario
      • 3.4.2.1 Why V-Shaped Recovery?
      • 3.4.2.2 Impact from Tariffs
      • 3.4.2.3 Market Dynamics and Demand Recovery
      • 3.4.2.4 Policy and Funding Support
      • 3.4.2.5 Timeframe for Recovery
    • 3.4.3 U Shaped Recovery Scenario
      • 3.4.3.1 Why U-Shaped Recovery?
      • 3.4.3.2 Impact from Tariffs
      • 3.4.3.3 Market Dynamics and Demand Recovery
      • 3.4.3.4 Policy and Funding Support
      • 3.4.3.5 Timeframe for Recovery
    • 3.4.4 L Shaped Recovery Scenario
      • 3.4.4.1 Why L-Shaped Recovery?
      • 3.4.4.2 Impact from Tariffs
      • 3.4.4.3 Market Dynamics and Demand Recovery
      • 3.4.4.4 Policy and Funding Support
      • 3.4.4.5 Timeframe for Recovery
    • 3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.4.6 Impact of U.S. and China Trade War on Cell and Gene Therapy Cold Chain Logistics Market
    • 3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
    • 3.4.8 Global Market Tariff Sensitivity and Margin Pressure Analysis
  • 3.5 Porter's Five Forces Analysis
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat from Substitutes
    • 3.5.5 Threat of New Entrants
  • 3.6 PEST Analysis

4 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Components

  • 4.1 Key Findings
  • 4.2 Components Segment: Market Attractiveness Index
  • 4.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 4.4 Cryogenic Shippers
    • 4.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Cryogenic Storage Freezers
    • 4.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)
  • 4.6 Ultra-Low Freezers
    • 4.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.6.2 Market Share by Region, 2025 & 2035 (%)
  • 4.7 Cold Chain Management Systems
    • 4.7.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.7.2 Market Share by Region, 2025 & 2035 (%)
  • 4.8 Shipment and Storage Medium
    • 4.8.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.8.2 Market Share by Region, 2025 & 2035 (%)
  • 4.9 Cryogenic Packout Kits
    • 4.9.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.9.2 Market Share by Region, 2025 & 2035 (%)
  • 4.10 Others
    • 4.10.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.10.2 Market Share by Region, 2025 & 2035 (%)

5 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Services

  • 5.1 Key Findings
  • 5.2 Services Segment: Market Attractiveness Index
  • 5.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 5.4 Transportation
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Storage
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Packaging
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)

6 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Mode of Transport

  • 6.1 Key Findings
  • 6.2 Mode of Transport Segment: Market Attractiveness Index
  • 6.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 6.4 Air Transport
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Ground Transport
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Water Transport
    • 6.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)

7 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Holding Temperature

  • 7.1 Key Findings
  • 7.2 Holding Temperature Segment: Market Attractiveness Index
  • 7.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 7.4 Cryogenic
    • 7.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Refrigerated
    • 7.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Ambient
    • 7.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
  • 7.7 Others
    • 7.7.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Cell and Gene Therapy Cold Chain Logistics Market Analysis by End-users

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-User
  • 8.4 Biopharmaceutical and Biotechnology Companies
    • 8.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 8.4.2 Market Share by Region, 2025 & 2035 (%)
  • 8.5 Academic & Research Institutes
    • 8.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 8.5.2 Market Share by Region, 2025 & 2035 (%)
  • 8.6 Others
    • 8.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 8.6.2 Market Share by Region, 2025 & 2035 (%)

9 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 10.3 North America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 10.4 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 10.5 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 10.6 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 10.7 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 10.8 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 10.9 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 10.10 U.S. Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 10.11 Canada Cell and Gene Therapy Cold Chain Logistics Market Analysis

11 Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 11.3 Europe Cell and Gene Therapy Cold Chain Logistics Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 11.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 11.5 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 11.6 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 11.7 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 11.8 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 11.9 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 11.10 Germany Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.11 UK Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.12 France Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.13 Italy Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.14 Spain Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.15 Russia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.16 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.17 Belgium Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 11.18 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis

12 Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 12.3 Asia Cell and Gene Therapy Cold Chain Logistics Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 12.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 12.5 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 12.6 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 12.7 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 12.8 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 12.9 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 12.10 Japan Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.11 China Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.12 India Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.13 Australia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.14 South Korea Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.15 Singapore Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.16 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.17 Thailand Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 12.18 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis

13 Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 13.3 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 13.4 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 13.5 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 13.6 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 13.7 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 13.8 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 13.9 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 13.10 Brazil Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.11 Mexico Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.12 Argentina Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 13.13 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis

14 MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • 14.3 MEA Cell and Gene Therapy Cold Chain Logistics Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 14.4 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
  • 14.5 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
  • 14.6 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
  • 14.7 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
  • 14.8 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
  • 14.9 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-user
  • 14.10 GCC Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 14.11 South Africa Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 14.12 Egypt Cell and Gene Therapy Cold Chain Logistics Market Analysis
  • 14.13 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2025
  • 15.2 Strategic Outlook
  • 15.3 Cencora, Inc.
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2021-2024
      • 15.3.3.2 Regional Market Shares, 2024
    • 15.3.4 Service Benchmarking
    • 15.3.5 Strategic Outlook
    • 15.3.6 SWOT Analysis
  • 15.4 Arvato SE
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Service Benchmarking
    • 15.4.4 Strategic Outlook
  • 15.5 Polar Express Transportation
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Service Benchmarking
  • 15.6 NMDP BioTherapies
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Service Benchmarking
    • 15.6.4 Strategic Outlook
  • 15.7 BioLife Solutions, Inc.
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2021-2024
      • 15.7.3.2 R&D, 2021-2024
      • 15.7.3.3 Segment Market Shares, 2024
    • 15.7.4 Service Benchmarking
    • 15.7.5 Strategic Outlook
    • 15.7.6 SWOT Analysis
  • 15.8 Cardinal Health
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2021-2024
      • 15.8.3.2 Regional Market Shares, 2024
      • 15.8.3.3 Segment Market Shares, 2024
    • 15.8.4 Service Benchmarking
    • 15.8.5 Strategic Outlook
    • 15.8.6 SWOT Analysis
  • 15.9 Catalent, Inc.
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2021-2024
      • 15.9.3.2 Regional Market Shares, 2024
      • 15.9.3.3 Segment Market Shares, 2024
    • 15.9.4 Service Benchmarking
    • 15.9.5 Strategic Outlook
    • 15.9.6 SWOT Analysis
  • 15.10 Cryoport Inc.
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2021-2024
      • 15.10.3.2 Regional Market Shares, 2024
      • 15.10.3.3 Segment Market Shares, 2024
    • 15.10.4 Service Benchmarking
    • 15.10.5 Strategic Outlook
    • 15.10.6 SWOT Analysis
  • 15.11 BioStor Sytems, Inc.
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Service Benchmarking
  • 15.12 Marken (A UPS Company)
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Service Benchmarking
    • 15.12.4 SWOT Analysis
  • 15.13 DHL Group
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Financial Analysis
      • 15.13.3.1 Net Revenue, 2021-2024
      • 15.13.3.2 Regional Market Shares, 2024
    • 15.13.4 Service Benchmarking
    • 15.13.5 Strategic Outlook
    • 15.13.6 SWOT Analysis
  • 15.14 FedEx
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Financial Analysis
      • 15.14.3.1 Net Revenue, 2021-2024
      • 15.14.3.2 Business Market Shares, 2024
    • 15.14.4 Service Benchmarking
    • 15.14.5 Strategic Outlook
    • 15.14.6 SWOT Analysis
  • 15.15 Thermo Fisher Scientific Inc.
    • 15.15.1 Company Snapshot
    • 15.15.2 Financial Analysis
      • 15.15.2.1 Net Revenue, 2021-2024
      • 15.15.2.2 R&D Expense, 2021-2024
      • 15.15.2.3 Regional Market Shares, 2024
      • 15.15.2.4 Regional Market Shares, 2024
    • 15.15.3 Company Overview
    • 15.15.4 Service Benchmarking
    • 15.15.5 Strategic Outlook
  • 15.16 Yourway
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Service Benchmarking
    • 15.16.4 Strategic Outlook
  • 15.17 A.P. Moller - Maersk
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2021-2024
      • 15.17.3.2 Regional Market Shares, 2024
      • 15.17.3.3 Segment Market Shares, 2024
    • 15.17.4 Service Benchmarking
    • 15.17.5 Strategic Outlook
  • 15.18 Atelerix Ltd
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Service Benchmarking
    • 15.18.4 Strategic Outlook
  • 15.19 Nordic Cold Chain Solutions
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Service Benchmarking
    • 15.19.4 Strategic Outlook
  • 15.20 MasterControl Solutions, Inc.
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Service Benchmarking
    • 15.20.4 Strategic Outlook
  • 15.21 TrakCel
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Service Benchmarking
    • 15.21.4 Strategic Outlook
  • 15.22 Modality Solutions
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Service Benchmarking
    • 15.22.4 Strategic Outlook
  • 15.23 SedApta s.r.l.
    • 15.23.1 Company Snapshot
    • 15.23.2 Company Overview
    • 15.23.3 Service Benchmarking
    • 15.23.4 Strategic Outlook
  • 15.24 Kuehne+Nagel
    • 15.24.1 Company Snapshot
    • 15.24.2 Company Overview
    • 15.24.3 Financial Analysis
      • 15.24.3.1 Net Revenue, 2021-2024
      • 15.24.3.2 Regional Market Shares, 2024
    • 15.24.4 Service Benchmarking
    • 15.24.5 Strategic Outlook
  • 15.25 YUSEN LOGISTICS CO., LTD.
    • 15.25.1 Company Snapshot
    • 15.25.2 Company Overview
    • 15.25.3 Service Benchmarking
    • 15.25.4 Strategic Outlook
  • 15.26 CEVA Logistics
    • 15.26.1 Company Snapshot
    • 15.26.2 Company Overview
    • 15.26.3 Service Benchmarking
    • 15.26.4 Strategic Outlook
  • 15.27 Delhivery Limited
    • 15.27.1 Company Snapshot
    • 15.27.2 Company Overview
    • 15.27.3 Financial Analysis
      • 15.27.3.1 Net Revenue, 2021-2024
    • 15.27.4 Service Benchmarking
    • 15.27.5 Strategic Outlook
  • 15.28 DB Schenker
    • 15.28.1 Company Snapshot
    • 15.28.2 Company Overview
    • 15.28.3 Financial Analysis
      • 15.28.3.1 Net Revenue, 2021-2024
    • 15.28.4 Service Benchmarking
    • 15.28.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players
Show more
Product Code: PHA1356

List of Tables

  • Table 1 Cell and Gene Therapy Cold Chain Logistics Market Snapshot, 2025 & 2035 (US$ Million, CAGR %)
  • Table 2 Major FDA Approved Cell and Gene Therapies
  • Table 3 Clinical Pipeline: Major Cell and Gene Therapies
  • Table 4 Cell and Gene Therapy Cold Chain Logistics Market: International Trade Tariff Impact Recovery Scenarios Snapshot
  • Table 5 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
  • Table 6 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
  • Table 7 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
  • Table 8 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 9 Cryogenic Shippers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 10 Cryogenic Storage Freezers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 11 Ultra-Low Freezers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 12 Cold Chain Management Systems Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 13 Shipment and Storage Medium Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 14 Cryogenic Packout Kits Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 16 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 17 Transportation Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 18 Storage Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 19 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 20 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 21 Air Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 22 Ground Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 23 Water Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 24 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 25 Cryogenic Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 26 Refrigerated Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 27 Ambient Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 28 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 29 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 30 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 31 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 32 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 33 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 34 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 35 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 36 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 37 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 38 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 39 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 40 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 41 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 42 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 43 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 44 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 45 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 46 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 47 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 48 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 49 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 50 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 51 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 52 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 53 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 54 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 55 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 56 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 57 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 58 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 59 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 60 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 61 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 62 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 63 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 64 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 65 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 66 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 67 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 68 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 69 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 70 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 71 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 72 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 73 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 74 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 75 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 76 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 77 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 78 Brazil Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 79 Mexico Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 80 Argentina Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 81 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 82 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 83 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 84 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 85 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 86 MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 87 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-User, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 88 GCC Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 89 South Africa Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 90 Egypt Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 91 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 92 Strategic Outlook
  • Table 93 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Cencora, Inc.: Service Benchmarking
  • Table 95 Cencora, Inc: Strategic Outlook
  • Table 96 Cencora, Inc: SWOT Analysis
  • Table 97 Arvato SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Arvato Systems: Service Benchmarking
  • Table 99 Arvato Systems Strategic Outlook
  • Table 100 Polar Express Transportation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Arvato Systems: Service Benchmarking
  • Table 102 NMDP BioTherapies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 NMDP BioTherapies: Service Benchmarking
  • Table 104 NMDP BioTherapies Strategic Outlook
  • Table 105 BioLife Solution Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 BioLife Solution Inc.: Service Benchmarking
  • Table 107 BioLife Solution Inc. Strategic Outlook
  • Table 108 BioLife Solution Inc.: SWOT Analysis
  • Table 109 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Cardinal Health: Service Benchmarking
  • Table 111 Cardinal Health: Strategic Outlook
  • Table 112 Cardinal Health: SWOT Analysis
  • Table 113 Catalent Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Catalent Inc.: Service Benchmarking
  • Table 115 Catalent Inc. Strategic Outlook
  • Table 116 Catalent Inc.: SWOT Analysis
  • Table 117 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Cryoport Inc.: Service Benchmarking
  • Table 119 Cryoport Inc.: Strategic Outlook
  • Table 120 Cryoport Inc.: SWOT Analysis
  • Table 121 BioStor Sytems, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 BioStor Sytems, Inc.: Service Benchmarking
  • Table 123 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Marken (A UPS Company): Service Benchmarking
  • Table 125 Marken (a UPS Company) Strategic Outlook
  • Table 126 Marken (a UPS Company): SWOT Analysis
  • Table 127 DHL Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 DHL Group: Service Benchmarking
  • Table 129 DHL: Strategic Outlook
  • Table 130 DHL: SWOT Analysis
  • Table 131 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 132 FedEx: Service Benchmarking
  • Table 133 FedEx: Strategic Outlook
  • Table 134 FedEx: SWOT Analysis
  • Table 135 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 137 Thermo Fisher Scientific Inc. Strategic Outlook
  • Table 138 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 139 Yourway: Service Benchmarking
  • Table 140 Yourway: Strategic Outlook
  • Table 141 A.P. Moller - Maersk: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 A.P. Moller - Maersk: Service Benchmarking
  • Table 143 A.P. Moller - Maersk: Strategic Outlook
  • Table 144 Atelerix Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 Atelerix Ltd: Service Benchmarking
  • Table 146 Atelerix Ltd: Strategic Outlook
  • Table 147 Nordic Cold Chain Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 148 Nordic Cold Chain Solutions: Service Benchmarking
  • Table 149 Nordic Cold Chain Solutions: Strategic Outlook
  • Table 150 MasterControl Solutions, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 151 MasterControl Solutions, Inc.: Service Benchmarking
  • Table 152 MasterControl Solutions, Inc.: Strategic Outlook
  • Table 153 TrakCel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 154 TrakCel: Service Benchmarking
  • Table 155 TrakCel: Strategic Outlook
  • Table 156 Modality Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 157 Modality Solutions: Service Benchmarking
  • Table 158 Modality Solutions: Strategic Outlook
  • Table 159 sedApta s.r.l.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 160 sedApta s.r.l.: Service Benchmarking
  • Table 161 sedApta s.r.l.: Strategic Outlook
  • Table 162 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 163 Kuehne+Nagel: Service Benchmarking
  • Table 164 Kuehne+Nagel: Strategic Outlook
  • Table 165 YUSEN LOGISTICS CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 166 YUSEN LOGISTICS CO., LTD.: Service Benchmarking
  • Table 167 YUSEN LOGISTICS CO., LTD.: Strategic Outlook
  • Table 168 CEVA Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 169 CEVA Logistics: Service Benchmarking
  • Table 170 CEVA Logistics: Strategic Outlook
  • Table 171 Delhivery Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 172 Delhivery Limited: Service Benchmarking
  • Table 173 Delhivery Limited: Strategic Outlook
  • Table 174 DB Schenker: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 175 DB Schenker: Service Benchmarking
  • Table 176 DB Schenker.: Strategic Outlook

List of Figures

  • Figure 1 Cell and Gene Therapy Cold Chain Logistics Market Segmentation
  • Figure 2 Cell and Gene Therapy Cold Chain Logistics Market by Component: Market Attractiveness Index
  • Figure 3 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Services
  • Figure 4 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Mode of Transport
  • Figure 5 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Holding Temperature Range
  • Figure 6 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by End-user
  • Figure 7 Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index by Region
  • Figure 8 Cell and Gene Therapy Cold Chain Logistics Market: Market Dynamics
  • Figure 9 Cell and Gene Therapy Cold Chain Logistics Market: Impact Analysis
  • Figure 10 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 11 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 12 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 13 Short Term & Long Term Planning
  • Figure 14 Impact of U.S. and China Trade War
  • Figure 15 Most Impacted Countries
  • Figure 16 Global Market Tariff Sensitivity and Margin Pressure Analysis
  • Figure 17 Cell and Gene Therapy Cold Chain Logistics Market: Porter's Five Forces Analysis
  • Figure 18 Cell and Gene Therapy Cold Chain Logistics Market: PEST Analysis
  • Figure 19 Cell and Gene Therapy Cold Chain Logistics Market by Components: Market Attractiveness Index
  • Figure 20 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR %)
  • Figure 21 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Components, 2025, 2030, 2035 (%)
  • Figure 22 Cryogenic Shippers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 23 Cryogenic Shippers Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 24 Cryogenic Storage Freezers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 25 Cryogenic Storage Freezers Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 26 Ultra-Low Freezers Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 27 Ultra-Low Freezers Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 28 Cold Chain Management Systems Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 29 Cold Chain Management Systems Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 30 Shipment and Storage Medium Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 31 Shipment and Storage Medium Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 32 Cryogenic Packout Kits Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 33 Cryogenic Packout Kits Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 36 Cell and Gene Therapy Cold Chain Logistics Market by Services: Market Attractiveness Index
  • Figure 37 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR %)
  • Figure 38 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Services, 2025, 2030, 2035 (%)
  • Figure 39 Transportation Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 40 Transportation Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 41 Storage Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 42 Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 43 Packaging Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 44 Packaging Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 45 Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transport: Market Attractiveness Index
  • Figure 46 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR %)
  • Figure 47 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Mode of Transport, 2025, 2030, 2035 (%)
  • Figure 48 Air Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 49 Air Transport Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 50 Ground Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 51 Ground Transport Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 52 Water Transport Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 53 Water Transport Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 54 Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature: Market Attractiveness Index
  • Figure 55 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR %)
  • Figure 56 Cell And Gene Therapy Cold Chain Logistics Share Forecast by Holding Temperature, 2025, 2030, 2035 (%)
  • Figure 57 Cryogenic Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 58 Cryogenic Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 Refrigerated Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 60 Refrigerated Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 61 Ambient Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 62 Ambient Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 63 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 64 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 65 Cell and Gene Therapy Cold Chain Logistics Market by End-users: Market Attractiveness Index
  • Figure 66 Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 67 Cell And Gene Therapy Cold Chain Logistics Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 68 Biopharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 69 Biopharmaceutical and Biotechnology Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 70 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 71 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 72 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 73 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 74 Cell and Gene Therapy Cold Chain Logistics Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
  • Figure 75 Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Region 2025, 2029, 2035 (%)
  • Figure 76 Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 77 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 78 North America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 79 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 80 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 81 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR %)
  • Figure 82 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2025 & 2035 (%)
  • Figure 83 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR %)
  • Figure 84 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 85 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR %)
  • Figure 86 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2025 & 2035 (%)
  • Figure 87 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR %)
  • Figure 88 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2025 & 2035 (%)
  • Figure 89 North America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2025-2035 (US$ Million, AGR %)
  • Figure 90 North America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2025 & 2035 (%)
  • Figure 91 U.S. Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 92 Canada Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 93 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 94 Europe Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 95 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 96 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 97 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR %)
  • Figure 98 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2025 & 2035 (%)
  • Figure 99 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR %)
  • Figure 100 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 101 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR %)
  • Figure 102 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2025 & 2035 (%)
  • Figure 103 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR %)
  • Figure 104 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2025 & 2035 (%)
  • Figure 105 Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2025-2035 (US$ Million, AGR %)
  • Figure 106 Europe Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2025 & 2035 (%)
  • Figure 107 Germany Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 108 UK Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 109 France Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 110 Italy Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 111 Spain Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 112 Russia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 113 Switzerland Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 114 Belgium Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 115 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 116 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 117 Asia Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 118 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 119 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 120 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR %)
  • Figure 121 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2025 & 2035 (%)
  • Figure 122 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR %)
  • Figure 123 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 124 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR %)
  • Figure 125 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2025 & 2035 (%)
  • Figure 126 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR %)
  • Figure 127 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2025 & 2035 (%)
  • Figure 128 Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2025-2035 (US$ Million, AGR %)
  • Figure 129 Asia Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by End-user, 2025 & 2035 (%)
  • Figure 130 Japan Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 131 China Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 132 India Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 133 Australia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 134 South Korea Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 135 Singapore Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 136 Malaysia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 137 Thailand Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 138 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 139 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
  • Figure 140 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 141 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 142 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 143 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Components, 2025-2035 (US$ Million, AGR %)
  • Figure 144 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Components, 2025 & 2035 (%)
  • Figure 145 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Services, 2025-2035 (US$ Million, AGR %)
  • Figure 146 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 147 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Mode of Transport, 2025-2035 (US$ Million, AGR %)
  • Figure 148 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Mode of Transport, 2025 & 2035 (%)
  • Figure 149 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by Holding Temperature, 2025-2035 (US$ Million, AGR %)
  • Figure 150 Latin America Cell and Gene Therapy Cold Chain Logistics Market Share Forecast by Holding Temperature, 2025 & 2035 (%)
  • Figure 151 Latin America Cell and Gene Therapy Cold Chain Logistics Market Forecast by End-user, 2025-2035 (US$ Million, AGR %)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!